148 related articles for article (PubMed ID: 29751345)
21. Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota.
Huang D; Wang Y; Xu C; Zou M; Ming Y; Luo F; Xu Z; Miao Y; Wang N; Lin Z; Weng Z
Int J Biol Macromol; 2024 May; 266(Pt 1):131107. PubMed ID: 38527677
[TBL] [Abstract][Full Text] [Related]
22. Oral delivery of curcumin via multi-bioresponsive polyvinyl alcohol and guar gum based double-membrane microgels for ulcerative colitis therapy.
Hu Y; Zhang S; Wen Z; Fu H; Hu J; Ye X; Kang L; Li X; Yang X
Int J Biol Macromol; 2022 Nov; 221():806-820. PubMed ID: 36099999
[TBL] [Abstract][Full Text] [Related]
23. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Kang NW; Kim MH; Sohn SY; Kim KT; Park JH; Lee SY; Lee JY; Kim DD
Biomaterials; 2018 Nov; 182():245-258. PubMed ID: 30142524
[TBL] [Abstract][Full Text] [Related]
24. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis.
Luo R; Lin M; Zhang C; Shi J; Zhang S; Chen Q; Hu Y; Zhang M; Zhang J; Gao F
Food Chem; 2020 Nov; 330():127241. PubMed ID: 32540526
[TBL] [Abstract][Full Text] [Related]
25. Oral delivery of porous starch-loaded bilayer microgels for controlled drug delivery and treatment of ulcerative colitis.
Wen Z; Kang L; Fu H; Zhu S; Ye X; Yang X; Zhang S; Hu J; Li X; Chen L; Hu Y; Yang X
Carbohydr Polym; 2023 Aug; 314():120887. PubMed ID: 37173037
[TBL] [Abstract][Full Text] [Related]
26. Oral delivery of curcumin
Chen Q; Si X; Ma L; Ma P; Hou M; Bai S; Wu X; Wan Y; Xiao B; Merlin D
J Mater Chem B; 2017 Aug; 5(29):5881-5891. PubMed ID: 29081976
[TBL] [Abstract][Full Text] [Related]
27. pH/ROS dual-sensitive and chondroitin sulfate wrapped poly (β-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis.
Xu H; Luo R; Dong L; Pu X; Chen Q; Ye N; Qi S; Han X; Nie W; Fu C; Hu Y; Zhang J; Gao F
Nanomedicine; 2022 Jan; 39():102461. PubMed ID: 34562656
[TBL] [Abstract][Full Text] [Related]
28. Oral colon-targeting core-shell microparticles loading curcumin for enhanced ulcerative colitis alleviating efficacy.
Zhang C; Chen Z; He Y; Xian J; Luo R; Zheng C; Zhang J
Chin Med; 2021 Sep; 16(1):92. PubMed ID: 34551815
[TBL] [Abstract][Full Text] [Related]
29. [Curcumin add-on therapy for ulcerative colitis].
Salomon N; Lang A; Gamus D
Harefuah; 2015 Jan; 154(1):56-8, 66. PubMed ID: 25796678
[TBL] [Abstract][Full Text] [Related]
30. Pluronic-Based Mixed Polymeric Micelles Enhance the Therapeutic Potential of Curcumin.
Akbar MU; Zia KM; Nazir A; Iqbal J; Ejaz SA; Akash MSH
AAPS PharmSciTech; 2018 Aug; 19(6):2719-2739. PubMed ID: 29978290
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
Arafa HM; Hemeida RA; El-Bahrawy AI; Hamada FM
Food Chem Toxicol; 2009 Jun; 47(6):1311-7. PubMed ID: 19285535
[TBL] [Abstract][Full Text] [Related]
32. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
[TBL] [Abstract][Full Text] [Related]
33. Sustained-Release Curcumin Microparticles for Effective Prophylactic Treatment of Exocrine Dysfunction of Pancreas: A Preclinical Study on Cerulein-Induced Acute Pancreatitis.
Anchi P; Khurana A; Swain D; Samanthula G; Godugu C
J Pharm Sci; 2018 Nov; 107(11):2869-2882. PubMed ID: 30031026
[TBL] [Abstract][Full Text] [Related]
34. Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice.
Sudirman S; Hsu YH; He JL; Kong ZL
PLoS One; 2018; 13(10):e0205252. PubMed ID: 30289911
[TBL] [Abstract][Full Text] [Related]
35. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
[TBL] [Abstract][Full Text] [Related]
36. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
[TBL] [Abstract][Full Text] [Related]
37. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
[TBL] [Abstract][Full Text] [Related]
38. Curcumin-Loaded Microspheres Are Effective in Preventing Oxidative Stress and Intestinal Inflammatory Abnormalities in Experimental Ulcerative Colitis in Rats.
Hales D; Muntean DM; Neag MA; Kiss B; Ștefan MG; Tefas LR; Tomuță I; Sesărman A; Rațiu IA; Porfire A
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080447
[TBL] [Abstract][Full Text] [Related]
39. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
[TBL] [Abstract][Full Text] [Related]
40. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
